Only line in the announcement potentially relating to potency assays is the last bit in my opinion - "...seeking to address all remaining product characterization issues".
Potency assay stuff is product characterization stuff - so that could be an acknowledgement (in an obscure general way - that they don't have an all clear on potency assay approach) but as I said "product characterization" is a broader term. It could pick up screening product for viral contamination etc and a bunch of other stuff unrelated to potency assays (as specific metrics intended to track product potency).
Only line in the announcement potentially relating to potency...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.155(16.7%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | $1.09 | 94.0¢ | $23.10M | 22.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13926 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 116987 | 8 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.155 ( 17.4 %) |
||||
| Open | High | Low | Volume | ||
| 94.0¢ | $1.09 | 94.0¢ | 3319494 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| MSB (ASX) Chart |